A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance
Kathryn Skivington, Lynsay Matthews, Sharon Anne Simpson et al. · BMJ · 2021
The UK Medical Research Council’s widely used guidance for developing and evaluating complex interventions has been replaced by a new framework, commissioned jointly by the Medical Research Council and the National Institute for Health Research, which takes account of recent developments in theory and methods and the need to maximise the efficiency, use, and impact of research.
Cited by 5,720 works. doi:10.1136/bmj.n2061 Open-access PDF
Authors
- Kathryn Skivington
- Lynsay Matthews
- Sharon Anne Simpson
- Peter Craig
- Janis Baird
- Jane M. Blazeby
- Kathleen Boyd
- Neil J. Craig
- David French
- Emma McIntosh
- Mark P. Petticrew
- Jo Rycroft‐Malone
- Martin J. White
- Laurence Moore
References
- Developing and evaluating complex interventions: the new Medical Research Council guidance
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
- Framework for design and evaluation of complex interventions to improve health
- Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
- Avoidable waste in the production and reporting of research evidence
- Process evaluation of complex interventions: Medical Research Council guidance
- Effectiveness-implementation Hybrid Designs
- Developing and Evaluating Complex Interventions: New Guidance
- Profits and pandemics: prevention of harmful effects of tobacco, alcohol, and ultra-processed food and drink industries
- Complex interventions: how “out of control” can a randomised controlled trial be?